Key facts
- This page summarizes Amy E. Weaver's Form 4 filing for Salesforce, Inc. (CRM).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Mar 2025, 17:40.
Amy E. Weaver - 17 Mar 2025 Form 4 Insider Report for Salesforce, Inc. (CRM)
- Reporting relationship
- President and CFO
- Issuer ticker
- CRM
- Reported as of
- 17 Mar 2025
- Net transaction value
- -$368,034
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2025, 17:40:27 UTC
- Prior SEC filing
- 04 Mar 2025
- Next SEC filing
- 02 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ryan Guerrero, Attorney-in-Fact for Amy Weaver
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Amy E. Weaver filed Form 4 for Salesforce, Inc. (CRM) on 18 Mar 2025.
Change
- Previous filing in this sequence was filed on 04 Mar 2025.
- Current net transaction value: -$368,034.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRM
transaction
Common Stock
Options Exercise
- Transaction value
- $1,357,484
- Shares
- +6,221
- Change %
- +13%
- Price
- $218.21
- Shares after
- 52,971
- Date
- 17 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
CRM
transaction
Common Stock
Sale
- Transaction value
- $1,725,519
- Shares
- -6,221
- Change %
- -12%
- Price
- $277.37
- Shares after
- 46,750
- Date
- 17 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRM
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -6,221
- Change %
- -14%
- Price
- $0.000000
- Shares after
- 37,235
- Date
- 17 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,221
- Exercise price
- $218.21
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 24, 2024.
Footnote F2
Option vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.